Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/01/23 → 6/06/23 |
Keywords
- Clinical trial
- Cystic Fibrosis
- genetic disorder
A Phase 2 Study of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Subjects with Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
- Kotsimbos, Tom (Primary Chief Investigator (PCI))
Project: Research